FDA decision: Gedatolisib by Celcuity Inc. (July 2026)
FDA decision: Gedatolisib by Celcuity Inc. (July 2026) Live odds across 5 markets: Full Approval at 81¢. Resolves Aug 1, 2026. Not financial advice.
Resolves Aug 1, 2026
- No Decision: Yes 9¢ (kalshi)
- Conditional / Accelerated Approval: Yes 11¢ (kalshi)
- Withdrawn by Sponsor: Yes 2¢ (kalshi)
- Full Approval: Yes 81¢ (kalshi)
- Denied (CRL Issued): Yes 11¢ (kalshi)
LIVE
8sFDA decision: Gedatolisib by Celcuity Inc. (July 2026)
Resolves Aug 1, 2026
Total Volume
$2.4K
+$0 (24h)
Active Markets
5
Across 1 platforms
Frontrunner
78¢
Full Approval
Biggest Mover 24h
-4¢
Conditional / Accelerated Approval
Arb Opportunities
0
None detected
All Markets
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | 78¢ | 81¢ | $846 | -3¢ | — | |
| 2 | 8¢ | 9¢ | $1.5K | -1¢ | — | |
| 3 | 8¢ | 11¢ | $0 | -4¢ | — | |
| 4 | 8¢ | 11¢ | $0 | -4¢ | — | |
| 5 | 1¢ | 2¢ | $60 | -1¢ | — |
Implied Probability
Consensus across platformsPrice History
Event Info
Whale Activity
Loading...